Treatment outcomes in the STAR study: a subanalysis of solifenacin 5 mg and tolterodine ER 4 mg. [electronic resource]
Producer: 20080226Description: 1195-203 p. digitalISSN:- 0302-2838
- Aged
- Benzhydryl Compounds -- adverse effects
- Cresols -- adverse effects
- Double-Blind Method
- Female
- Humans
- Male
- Middle Aged
- Muscarinic Antagonists -- adverse effects
- Phenylpropanolamine -- adverse effects
- Quinuclidines -- adverse effects
- Safety
- Solifenacin Succinate
- Tetrahydroisoquinolines -- adverse effects
- Tolterodine Tartrate
- Treatment Outcome
- Urinary Bladder, Overactive -- drug therapy
- Urinary Incontinence, Stress -- drug therapy
- Urination -- drug effects
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.